1. Home
  2. MG vs AURA Comparison

MG vs AURA Comparison

Compare MG & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

N/A

Current Price

$20.21

Market Cap

642.4M

ML Signal

N/A

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

N/A

Current Price

$7.12

Market Cap

631.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MG
AURA
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.4M
631.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
MG
AURA
Price
$20.21
$7.12
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
★ $21.18
$16.60
AVG Volume (30 Days)
347.1K
★ 741.8K
Earning Date
11-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.51
N/A
Revenue
★ $700,970,000.00
N/A
Revenue This Year
$3.15
N/A
Revenue Next Year
$5.40
N/A
P/E Ratio
$39.63
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.13
$4.73
52 Week High
$21.92
$9.54

Technical Indicators

Market Signals
Indicator
MG
AURA
Relative Strength Index (RSI) 43.61 56.99
Support Level $20.06 $6.65
Resistance Level $21.77 $7.83
Average True Range (ATR) 0.11 0.41
MACD -0.04 0.09
Stochastic Oscillator 30.61 59.56

Price Performance

Historical Comparison
MG
AURA

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: